CG Oncology (CGON) Non-cash Items (2023 - 2026)

CG Oncology (CGON) has 4 years of Non-cash Items data on file, last reported at $382.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 338.54% year-over-year to $382.9 million; the trailing twelve-month figure through Mar 2026 stood at $382.9 million (up 338.54% YoY), and the FY2025 full-year result was $198.5 million, up 83.57% from the prior year.
• Non-cash Items for Q1 2026 stood at $382.9 million, up from $198.5 million in the prior quarter.
• Across five years, Non-cash Items topped out at $382.9 million in Q1 2026 and bottomed at $40.3 million in Q4 2023.
• The 4-year median for Non-cash Items is $155.1 million (2024), against an average of $165.6 million.
• The widest annual swing landed in 2025, when Non-cash Items sank 62.23%; it then soared 338.54% in 2026.
• A 4-year view of Non-cash Items shows it stood at $40.3 million in 2023, then surged by 168.44% to $108.2 million in 2024, then surged by 83.57% to $198.5 million in 2025, then surged by 92.85% to $382.9 million in 2026.
• The last three Non-cash Items figures came in at $382.9 million (Q1 2026), $198.5 million (Q4 2025), and $190.7 million (Q3 2025), per Business Quant data.

Peer Comparison